[go: up one dir, main page]

ATE245028T1 - Trimegestone enthaltende pharmazeutische zusammensetzungen - Google Patents

Trimegestone enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE245028T1
ATE245028T1 AT00981453T AT00981453T ATE245028T1 AT E245028 T1 ATE245028 T1 AT E245028T1 AT 00981453 T AT00981453 T AT 00981453T AT 00981453 T AT00981453 T AT 00981453T AT E245028 T1 ATE245028 T1 AT E245028T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
trimegestone
containing trimegestone
composition
Prior art date
Application number
AT00981453T
Other languages
English (en)
Inventor
Philippe Becourt
Robert Georges
Chicq Serge Segot
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE245028T1 publication Critical patent/ATE245028T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00981453T 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen ATE245028T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914714A FR2801218B1 (fr) 1999-11-23 1999-11-23 Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
PCT/FR2000/003240 WO2001037841A1 (fr) 1999-11-23 2000-11-22 Compositions pharmaceutiques comprenant de la trimegestone

Publications (1)

Publication Number Publication Date
ATE245028T1 true ATE245028T1 (de) 2003-08-15

Family

ID=9552429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981453T ATE245028T1 (de) 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen

Country Status (11)

Country Link
US (1) US7732431B2 (de)
EP (1) EP1235579B1 (de)
JP (1) JP5060005B2 (de)
AT (1) ATE245028T1 (de)
AU (1) AU1869601A (de)
DE (1) DE60003943T2 (de)
DK (1) DK1235579T3 (de)
ES (1) ES2200978T3 (de)
FR (1) FR2801218B1 (de)
PT (1) PT1235579E (de)
WO (1) WO2001037841A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
AU2006271920A1 (en) * 2005-07-20 2007-01-25 Grunenthal Gmbh Oral contraception with trimegestone
EP2108371A1 (de) * 2008-04-08 2009-10-14 Grünenthal GmbH Estra-1,3,5(10)-trien-Derivate zur Kontrazeption
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth
MX364743B (es) 2013-07-11 2019-05-06 Evestra Inc Profármacos de formación de compuestos.
BR112019014841A2 (pt) 2017-01-23 2020-04-28 Regeneron Pharma rna guia, uso do rna guia, rna antissentido, sirna ou shrna, uso do rna antissentido, do sirna ou do shrna, ácido nucleico isolado, vetor, composição, célula, e, métodos para modificar um gene hsd17b13 em uma célula, para diminuir a expressão de um gene hsd17b13 em uma célula, para modificar uma célula e para tratar um indivíduo que não é portador da variante de hsd17b13
EP3610029A1 (de) * 2017-04-11 2020-02-19 Regeneron Pharmaceuticals, Inc. Tests zum screening der aktivität von modulatoren von elementen der hydroxysteroid (17-beta)-dehydrogenase (hsd17b)-familie
SG11202003254SA (en) 2017-10-11 2020-05-28 Regeneron Pharma Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m variation
WO2019078983A1 (en) 2017-10-19 2019-04-25 Evestra, Inc. CONTRACEPTIVES OF PROGESTINE PRODRANT WITH EXTENDED ACTION
SG11202007583SA (en) 2018-03-21 2020-09-29 Regeneron Pharma 17β-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239646A (en) * 1974-09-23 1980-12-16 Champion International Corporation Microspheric opacifying agents and method for their production
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
FR2692267B1 (fr) * 1992-06-11 1995-05-19 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.
FR2694007B1 (fr) * 1992-07-23 1994-09-30 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21 (S) hydroxy et des intermédiaires.
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
HU223943B1 (hu) * 1995-06-22 2005-03-29 Akzo Nobel N.V. Dezogesztrelt tartalmazó, szárazon granulált, sajtolt tabletták és előállításuk
FR2749012B1 (fr) * 1996-05-22 1998-08-07 Hoechst Marion Roussel Inc Nouveaux steroides 1 ou 6-hydroxyles, leur procede de preparation, leur application a titre de medicament et les compositions pharmaceutiques les renfermant
AU4043597A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
HUP9904345A3 (en) * 1996-07-26 2000-11-28 Wyeth Corp Oral contraceptive
DE69729956T2 (de) * 1996-07-26 2004-12-16 Wyeth Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
US5858405A (en) 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
AU3888597A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
SG125044A1 (en) * 1996-10-14 2006-09-29 Mitsubishi Gas Chemical Co Oxygen absorption composition
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives

Also Published As

Publication number Publication date
PT1235579E (pt) 2003-12-31
US7732431B2 (en) 2010-06-08
AU1869601A (en) 2001-06-04
EP1235579B1 (de) 2003-07-16
FR2801218A1 (fr) 2001-05-25
ES2200978T3 (es) 2004-03-16
DE60003943D1 (de) 2003-08-21
DE60003943T2 (de) 2004-05-27
US20070219169A1 (en) 2007-09-20
DK1235579T3 (da) 2003-10-20
WO2001037841A1 (fr) 2001-05-31
FR2801218B1 (fr) 2001-12-28
EP1235579A1 (de) 2002-09-04
JP5060005B2 (ja) 2012-10-31
JP2003514861A (ja) 2003-04-22

Similar Documents

Publication Publication Date Title
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
AP9901534A0 (en) Pharmaceutical formulations.
MY126897A (en) Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
ES2114487B1 (es) Mezcla estabilizante sinergistica.
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
YU15299A (sh) Farmaceutski sastavi
SE9704546D0 (sv) Novel compounds
MY124487A (en) Dolastatin derivatives, their preparation and use
HK1029060A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
GB2364641A (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
YU13301A (sh) Muskarinski agonisti i antagonisti
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
BG105539A (en) Eletriptan hydrobromide monohydrate
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2191625T3 (es) Composicion oral que contiene perlita.
ES2179375T3 (es) Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion.
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.
DE69900466D1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
EP0457127A3 (en) Spermicidal coating

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1235579

Country of ref document: EP